ストックスクリーナーアプリを入手
3.68
4.42%
-0.17
アフターアワーズ：
3.80
0.12
+3.26%
前日終値:
$3.85
開ける：
$3.85
24時間の取引高:
49,552
Relative Volume:
0.93
時価総額：
$244.49M
収益：
$64.49M
当期純損益:
$-71.40M
株価収益率:
-3.3761
EPS:
-1.09
ネットキャッシュフロー:
$-52.00M
1週間 パフォーマンス:
+1.38%
1か月 パフォーマンス:
+27.34%
6か月 パフォーマンス:
+13.58%
1年 パフォーマンス:
-23.33%
1日の値動き範囲:
$3.68
$3.85
1週間の範囲:
$3.51
$3.9276
52週間の値動き範囲:
$2.70
$7.37
Sophia Genetics Sa Stock (SOPH) Company Profile
SOPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
3.68 | 244.49M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
234.33 | 38.04B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
74.94 | 14.06B | 516.85M | 174.11M | 217.38M | 0.87 |
|
SOLV
Solventum Corp
|
73.65 | 12.72B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
71.21 | 11.21B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
112.50 | 9.75B | 1.15B | 96.70M | -161.99M | 1.09 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-18 | 開始されました | Craig Hallum | Buy |
| 2024-08-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | 開始されました | Guggenheim | Buy |
| 2023-11-29 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-01-03 | 開始されました | BTIG Research | Buy |
| 2022-11-23 | 開始されました | Credit Suisse | Neutral |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-17 | 開始されました | Cowen | Outperform |
| 2021-08-17 | 開始されました | Credit Suisse | Outperform |
| 2021-08-17 | 開始されました | JP Morgan | Overweight |
| 2021-08-17 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Sophia Genetics Sa (SOPH) 最新ニュース
SOPHiA GENETICS (NASDAQ:SOPH) Shares Down 4.4% – Here’s Why - Defense World
Analyzing Caribou Biosciences (NASDAQ:CRBU) & SOPHiA GENETICS (NASDAQ:SOPH) - Defense World
Clear Channel Outdoor Holdings Inc (CCO) Shares Plummet Below 1-Year High - The News Heater
SOPHiA Genetics SA (SOPH) Stock: Analyzing the Market Value - The News Heater
Anavex Life Sciences Corporation (AVXL) Stock: Assessing the Risk and Reward - The News Heater
Stock market today: Haoxi Health Technology -30.00%, Planet Image International -26.26% among biggest losers in early trading - Business Upturn
SOPHSOPHiA GENETICS SA Ordinary Shares Latest Stock News & Market Updates - StockTitan
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities -January 28, 2025 at 08:47 am EST - Marketscreener.com
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities – Company Announcement - Financial Times
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities - Barchart
Game-Changing Cancer Detection Tool Spots What Others Miss: New Breakthrough from SOPHiA GENETICS - StockTitan
Tempus AI Stock Before Q4 Earnings: To Buy Or Not To Buy? - Barchart
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Bioinformatics Market Analysis: Key Trends, Growth Drivers and Key Companies 2025 – 2032 - Newstrail
AI In Genomics Global Market Report 2024: Exponential Market - openPR
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Decreases By 15.1% - MarketBeat
3 US Penny Stocks With Market Caps Under $200M - Simply Wall St
Shareholders Should Be Pleased With SOPHiA GENETICS SA's (NASDAQ:SOPH) Price - Simply Wall St
Genomic Biomarkers Market Report: Personalized Medicine - GlobeNewswire
Genomic Biomarkers Market Report: Personalized Medicine Powers 17.4% CAGR in Genomic Biomarkers Through 2028 - Yahoo Finance
The Zacks Analyst Blog Highlights Tempus AI, iRhythm Technologies and SOPHiA GENETICS - Yahoo Finance
Tempus AI Stock Surges 23% In 6 Months: Should You Snap It Up Now? - Barchart
Radiomics Market Top Companies StudyRadiomics.io - openPR
Principal Financial Group Inc. Buys 86,764 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
JPMorgan Chase & Co. Purchases 1,399,131 Shares of iShares 5-10 Year Investment Grade Corporate Bond ETF (NASDAQ:IGIB) - Defense World
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 38.6% - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Coverage Initiated at Craig Hallum - Defense World
Guggenheim Initiates Coverage of SOPHiA GENETICS (SOPH) with Buy Recommendation - MSN
Growth Trends in Europe's Precision Medicine Software - GlobeNewswire
Growth Trends in Europe's Precision Medicine Software Market: Focus on Product Type, Application, End User, and CountryAnalysis and Forecast, 2024-2033 - GlobeNewswire
SOPHiA GENETICS (NASDAQ:SOPH) Now Covered by Analysts at Craig Hallum - MarketBeat
Craig-Hallum Initiates Coverage of SOPHiA GENETICS (SOPH) with Buy Recommendation - MSN
SOPHiA GENETICS's SWOT analysis: biopharma firm navigates headwinds, eyes growth - Investing.com Australia
SOPHiA GENETICS's SWOT analysis: biopharma firm navigates headwinds, eyes growth By Investing.com - Investing.com South Africa
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
Precision Medicine Software Market to Witness Substantial Growth and New Opportunities from 2024 to 2031 As... - WhaTech
US Penny Stocks To Watch In December 2024 - Simply Wall St
Bioinformatics Market to Grow by USD 13.2 Billion (2024-2028), Lower Genetic Sequencing Costs Drive Revenue, Report Highlights AI's Role in TransformationTechnavio - The Malaysian Reserve
SOPHiA GENETICS Reports Third Quarter 2024 Results - GuruFocus.com
Principal Financial Group Inc. Acquires 86,764 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024 – Company Announcement - Financial Times
SOPHiA GENETICS Launches Advanced Cancer Profiling Platform with 99.3% Accuracy - StockTitan
SOPHiA GENETICS's SWOT analysis: data-driven medicine stock faces headwinds - Investing.com India
SOPHiA GENETICS (NASDAQ:SOPH) vs. SpringWorks Therapeutics (NASDAQ:SWTX) Financial Review - Defense World
Earnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00 - Yahoo Finance
SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: SOPHiA GENETICS reported a16% year-over-year increase in analysis volume - Investing.com
SOPHiA GENETICS Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
SOPHiA GENETICS Q3 2024 Financial Highlights - TipRanks
SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer - Marketscreener.com
Sophia Genetics Sa (SOPH) 財務データ
収益
当期純利益
現金流量
EPS
1.00%
0.46%
大文字化:
|
ボリューム (24 時間):